Cargando…

Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers

BACKGROUND: Over recent years, enzymes of the aldo-keto reductase (AKR) 1C subfamily have been implicated in the progression of prostate, breast, endometrial and leukemic cancers. This is due to the ability of AKR1C enzymes to modify androgens, estrogens, progesterone and prostaglandins (PGs) in a t...

Descripción completa

Detalles Bibliográficos
Autores principales: Veliça, Pedro, Davies, Nicholas J, Rocha, Pedro P, Schrewe, Heinrich, Ride, Jonathan P, Bunce, Chris M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805611/
https://www.ncbi.nlm.nih.gov/pubmed/20003443
http://dx.doi.org/10.1186/1476-4598-8-121
_version_ 1782176202158505984
author Veliça, Pedro
Davies, Nicholas J
Rocha, Pedro P
Schrewe, Heinrich
Ride, Jonathan P
Bunce, Chris M
author_facet Veliça, Pedro
Davies, Nicholas J
Rocha, Pedro P
Schrewe, Heinrich
Ride, Jonathan P
Bunce, Chris M
author_sort Veliça, Pedro
collection PubMed
description BACKGROUND: Over recent years, enzymes of the aldo-keto reductase (AKR) 1C subfamily have been implicated in the progression of prostate, breast, endometrial and leukemic cancers. This is due to the ability of AKR1C enzymes to modify androgens, estrogens, progesterone and prostaglandins (PGs) in a tissue-specific manner, regulating the activity of nuclear receptors and other downstream effects. Evidence supporting a role for AKR1C enzymes in cancer derives mostly from studies with isolated primary cells from patients or immortalized cell lines. Mice are ideal organisms for in vivo studies, using knock-out or over-expression strains. However, the functional conservation of AKR1C enzymes between human and mice has yet to be described. RESULTS: In this study, we have characterized and compared the four human (AKR1C1,-1C2, -1C3 and -1C4) and the eight murine (AKR1C6, -1C12, -1C13, -1C14, -1C18, -1C19, -1C20 and -1C21) isoforms in their phylogeny, substrate preference and tissue distribution. We have found divergent evolution between human and murine AKR1C enzymes that was reflected by differing substrate preference. Murine enzymes did not perform the 11β-ketoreduction of prostaglandin (PG) D(2), an activity specific to human AKR1C3 and important in promoting leukemic cell survival. Instead, murine AKR1C6 was able to perform the 9-ketoreduction of PGE(2), an activity absent amongst human isoforms. Nevertheless, reduction of the key steroids androstenedione, 5α-dihydrotestosterone, progesterone and estrone was found in murine isoforms. However, unlike humans, no AKR1C isoforms were detected in murine prostate, testes, uterus and haemopoietic progenitors. CONCLUSIONS: This study exposes significant lack of phylogenetic and functional homology between human and murine AKR1C enzymes. Therefore, we conclude that mice are not suitable to model the role of AKR1C in human cancers and leukemia.
format Text
id pubmed-2805611
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28056112010-01-13 Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers Veliça, Pedro Davies, Nicholas J Rocha, Pedro P Schrewe, Heinrich Ride, Jonathan P Bunce, Chris M Mol Cancer Research BACKGROUND: Over recent years, enzymes of the aldo-keto reductase (AKR) 1C subfamily have been implicated in the progression of prostate, breast, endometrial and leukemic cancers. This is due to the ability of AKR1C enzymes to modify androgens, estrogens, progesterone and prostaglandins (PGs) in a tissue-specific manner, regulating the activity of nuclear receptors and other downstream effects. Evidence supporting a role for AKR1C enzymes in cancer derives mostly from studies with isolated primary cells from patients or immortalized cell lines. Mice are ideal organisms for in vivo studies, using knock-out or over-expression strains. However, the functional conservation of AKR1C enzymes between human and mice has yet to be described. RESULTS: In this study, we have characterized and compared the four human (AKR1C1,-1C2, -1C3 and -1C4) and the eight murine (AKR1C6, -1C12, -1C13, -1C14, -1C18, -1C19, -1C20 and -1C21) isoforms in their phylogeny, substrate preference and tissue distribution. We have found divergent evolution between human and murine AKR1C enzymes that was reflected by differing substrate preference. Murine enzymes did not perform the 11β-ketoreduction of prostaglandin (PG) D(2), an activity specific to human AKR1C3 and important in promoting leukemic cell survival. Instead, murine AKR1C6 was able to perform the 9-ketoreduction of PGE(2), an activity absent amongst human isoforms. Nevertheless, reduction of the key steroids androstenedione, 5α-dihydrotestosterone, progesterone and estrone was found in murine isoforms. However, unlike humans, no AKR1C isoforms were detected in murine prostate, testes, uterus and haemopoietic progenitors. CONCLUSIONS: This study exposes significant lack of phylogenetic and functional homology between human and murine AKR1C enzymes. Therefore, we conclude that mice are not suitable to model the role of AKR1C in human cancers and leukemia. BioMed Central 2009-12-14 /pmc/articles/PMC2805611/ /pubmed/20003443 http://dx.doi.org/10.1186/1476-4598-8-121 Text en Copyright ©2009 Veliça et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Veliça, Pedro
Davies, Nicholas J
Rocha, Pedro P
Schrewe, Heinrich
Ride, Jonathan P
Bunce, Chris M
Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers
title Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers
title_full Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers
title_fullStr Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers
title_full_unstemmed Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers
title_short Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers
title_sort lack of functional and expression homology between human and mouse aldo-keto reductase 1c enzymes: implications for modelling human cancers
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805611/
https://www.ncbi.nlm.nih.gov/pubmed/20003443
http://dx.doi.org/10.1186/1476-4598-8-121
work_keys_str_mv AT velicapedro lackoffunctionalandexpressionhomologybetweenhumanandmousealdoketoreductase1cenzymesimplicationsformodellinghumancancers
AT daviesnicholasj lackoffunctionalandexpressionhomologybetweenhumanandmousealdoketoreductase1cenzymesimplicationsformodellinghumancancers
AT rochapedrop lackoffunctionalandexpressionhomologybetweenhumanandmousealdoketoreductase1cenzymesimplicationsformodellinghumancancers
AT schreweheinrich lackoffunctionalandexpressionhomologybetweenhumanandmousealdoketoreductase1cenzymesimplicationsformodellinghumancancers
AT ridejonathanp lackoffunctionalandexpressionhomologybetweenhumanandmousealdoketoreductase1cenzymesimplicationsformodellinghumancancers
AT buncechrism lackoffunctionalandexpressionhomologybetweenhumanandmousealdoketoreductase1cenzymesimplicationsformodellinghumancancers